Citation Impact
Citing Papers
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
2011
“Inflammatory” Cytokines
2000
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
2004 Standout
Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 Receptor
2001 StandoutNobel
TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms
1991
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
A Macrophage‐Targeted Theranostic Nanoparticle for Biomedical Applications
2006
Roles of the ankyrin repeats and C-terminal region of the mouse Notch1 intracellular region
1998 StandoutNobel
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Prosthetic-Joint Infections
2004 Standout
RAG-1-deficient mice have no mature B and T lymphocytes
1992 StandoutNobel
Imaging in the era of molecular oncology
2008 StandoutNature
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system
1991 Nobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
In vivo near-infrared fluorescence imaging of osteoblastic activity
2001
Photodynamic therapy for cancer
2003 Standout
Immune-Neuro-Endocrine Interactions: Facts and Hypotheses
1996
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Apop-1, a Novel Protein Inducing Cyclophilin D-dependent but Bax/Bak-related Channel-independent Apoptosis
2006 StandoutNobel
Photosensitizers in clinical PDT
2004
The development of allergic inflammation
2008 StandoutNature
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
2003 StandoutNature
Oncologic photodynamic therapy photosensitizers: A clinical review
2010
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
1998 StandoutNature
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
The CDK inhibitors in cancer research and therapy
2011
The physics, biophysics and technology of photodynamic therapy
2008
Interleukin‐12 and B7.1 co‐stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors
1996
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Immunological mechanisms of allergen-specific immunotherapy
2006
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
1996 StandoutNature
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
2003
Angiogenesis as a therapeutic target
2005 StandoutNature
Circulating Angiogenic Factors and the Risk of Preeclampsia
2004 Standout
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Role of apoptosis in atherosclerosis and its therapeutic implications
2004
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Vasoactive Intestinal Peptide Synergizes with TNF-α in Inducing Human Dendritic Cell Maturation
1999
A Review of Progress in Clinical Photodynamic Therapy
2005
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
AUUUA Is Not Sufficient To Promote Poly(A) Shortening and Degradation of an mRNA: the Functional Sequence within AU-Rich Elements May Be UUAUUUA(U/A)(U/A)
1994
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
2004
Expression and regulation of brain metallothionein
1995
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
1995 StandoutNobel
Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease
2004
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Phase I Drug and Light Dose-Escalation Trial of Motexafin Lutetium and Far Red Light Activation (Phototherapy) in Subjects With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention and Stent Deployment
2003
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Acute Septic Arthritis
2002
Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
2010
Calcitonin Gene-Related Peptide Decreases Expression of HLA-DR and CD86 by Human Dendritic Cells and Dampens Dendritic Cell-Driven T Cell-Proliferative Responses Via the Type I Calcitonin Gene-Related Peptide Receptor
2000 StandoutNobel
Biology and Clinical Development of Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma
2004
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Recombination of exogenous interleukin 2 receptor gene flanked by immunoglobulin recombination signal sequences in a pre-B cell line and transgenic mice.
1991 StandoutNobel
Fluorescent Sensors for Zn2+Based on a Fluorescein Platform: Synthesis, Properties and Intracellular Distribution
2001 StandoutNobel
Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions
2005
Engineering InAsxP1-x/InP/ZnSe III−V Alloyed Core/Shell Quantum Dots for the Near-Infrared
2005 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
The History of Photodetection and Photodynamic Therapy¶
2001
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer
2004
Emerging Targets in Photopharmacology
2016 StandoutNobel
Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation.
1999
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
2010
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
2005
Recombination signal sequence-binding protein Jκ alters mesodermal cell fate decisions by suppressing cardiomyogenesis
2003 StandoutNobel
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer
2002
Works of Daniel C. Adelman being referenced
Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials
2011
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors
2007
Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide
1993
Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetium
2002
CD45 isoforms on human CD4+ T-cell subsets
1996
Neuroimmunology
1990
Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation.
1990
Imipenem cross-reactivity with penicillin in humans
1988
Effect of Aerosolized Anti-IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects
1999
Costimulatory signals can selectively modulate cytokine production by subsets of CD4+ T cells.
1995
Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data
2001
Down-Regulation of Human Basophil IgE and FCεRIα Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo
1999
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma
1999
Photodynamic Therapy With Motexafin Lutetium Induces Redox-Sensitive Apoptosis of Vascular Cells
2001
482 Unique suppression of human blood mononuclear leukocyte (ML) production of IgG by prolonged exposure to vasoactive intestinal peptide (VIP)
1991
Photoangioplasty for Human Peripheral Atherosclerosis
2000
Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
2001